Items

• Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA. (2015)

  B. Mirjanic-Azaric, Z. Jelic-Ivanovic, A. Zeljkovic, J. Vekic, G. Jurgens, T. Milivojac, S. Avram, J. Coric, J. Marc, D. Cerne, Atorvastatin pleiotropic effects on stable angina patients: evidence by analysis of high-density lipoprotein size and subclasses, and plasma mRNA., JOURNAL OF MEDICAL BIOCHEMISTRY, Vol. 34, pp. 314 - 322, 2015

• Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients. (2015)

  B. Mirjanic-Azaric, M. Rizzo, G. Jurgens, S. Hallstroem, s. Srdic, J. Marc, D. Cerne, Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients., SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, Vol. 75, pp. 382 - 389, 2015

• CORRELATIONS OF CATHEPSIN S WITH LIPOPROTEIN SUBCLASSES LEVELS AND LIPID PARAMETERS IN PATIENTS WITH STABLE ANGINA (2017-08)

  B. Mirjanić-Azarić, A. Zeljkovic, J. Vekic, G. Jurgens, CORRELATIONS OF CATHEPSIN S WITH LIPOPROTEIN SUBCLASSES LEVELS AND LIPID PARAMETERS IN PATIENTS WITH STABLE ANGINA, Atherosclerosis,August 201 7Volume 263, Pages e213–e214, pp. e213 - e214, Aug, 2017